Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Sai Life Sciences Ltd. Share Price
Day's Range
Low
₹1,470.60
High
₹1,518.90
Price Summary
| Previous Close | ₹1,487.90 |
|---|---|
| Day's Range | ₹1,470.60 - ₹1,518.90 |
| Open | ₹1,509.80 |
| 52 Week Range | ₹783.85 - ₹1,697.00 |
| Volume | 4,29,336 |
| Market Cap | ₹0.03 |
| Previous Close | ₹1,488.25 |
|---|---|
| Day's Range | ₹1,468.80 - ₹1,516.20 |
| Open | ₹1,508.40 |
| 52 Week Range | ₹786.15 - ₹1,697.00 |
| Volume | 58,726 |
| Market Cap | ₹0.03 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 6,394.51 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 87.39 |
| TTM EPS (₹) | 17.03 |
| P/E Ratio | 58.91 |
| Book Value(₹) | 12.38 |
| PAT Margin (%) | 15.89 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 20.97 |
| Trade Value ( ₹ in Lacs) | 873.93 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 87.39 |
| TTM EPS (₹) | 17.03 |
| P/E Ratio | 58.91 |
| Book Value(₹) | 12.38 |
| PAT Margin (%) | 15.89 |
| Face Value (₹) | 1.00 |
| ROCE(%) | 20.97 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 4830.38 | 16420.48 |
| Expenses | N/A | N/A |
| PBT | 779.82 | 2317.16 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 583.7 | 1734.62 |
About Sai Life Sciences Ltd.
| Founded | 1999 |
|---|---|
| Managing Director | Krishnam Raju Kanumuri |
| NSE Symbol | SAILIFE |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,21,539.16 | 1,756.90 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 2,47,576.00 | 9,326.00 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,77,251.42 | 4,660.00 | 3,480.60 - 3,480.60 |
| Lenskart Solutions Ltd. | 1,17,881.48 | 677.95 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,15,315.29 | 8,020.00 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,11,231.65 | 1,115.10 | 835.50 - 835.50 |
| Laurus Labs Ltd. | 1,09,796.85 | 2,032.10 | 843.00 - 843.00 |
| Cipla Ltd. | 1,05,289.78 | 1,303.30 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 99,752.64 | 1,195.10 | 1,101.00 - 1,101.00 |
| Mankind Pharma Ltd. | 97,850.38 | 2,372.20 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Sai Life Sciences submits board meeting intimation
Sai Life Sciences informs about outcome of AGM
Sai Life Sciences informs about allotment of equity shares under ESOP
Sai Life Sciences has informed that, pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations the Board of Directors by the way of Circular Resolution on 01st September 2026, had approved the allotment of 14,600 and 66,000 fully paid-up equity shares having a face value of ₹1 each upon exercise of options granted under ESOP 2008 and MESOP 2018 respectively. Consequent to aforesaid allotment the issued, subscribed, and paid-up equity share capital of the Company has increased from ₹21,23,13,617 to ₹21,23,94,216. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (‘SEBI ESOP Regulations 2021’) are enclosed as Annexure-A.
The above information is a part of company’s filings submitted to BSE.
Max Healthcare Institute informs about credit rating
Max Healthcare Institute has informed about credit rating. CARE Ratings has upgraded the credit rating for Crosslay Remedies (formerly ‘Jaypee Healthcare Limited’) a wholly-owned material subsidiary of the Company.
The above information is a part of company’s filings submitted to BSE.
Cohance Lifesciences informs about stock options
Cohance Lifesciences has informed about Grant of Stock options to certain eligible employees of the Company.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Sai Life Sciences Ltd. is ₹1,487.90 as of 2026-10-09.
The market capitalisation of Sai Life Sciences Ltd. is ₹31,613.14 as of 2026-10-09.
The 1-year return of Sai Life Sciences Ltd. is 626.45% as of 2026-10-09.
The P/E ratio of Sai Life Sciences Ltd. is 58.91 as of 2026-10-11.
The 52-week high and low of Sai Life Sciences Ltd. are ₹1,697.00 and ₹783.85, respectively, as of 2026-10-09.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
